Fungal contamination sparks new IV compounded drugs recall
This article was originally published in Scrip
Executive Summary
Only a week after FDA Commissioner Dr Margaret Hamburg warned that another crisis could occur similar to the fungal meningitis outbreak in which 50 Americans have died, with more than 720 stricken ill, the agency alerted health care providers about a recall of all products made by a New Jersey compounding pharmacy – warning that vials of magnesium sulfate intravenous solution were contaminated with fungus.